183 related articles for article (PubMed ID: 7686737)
21. Thiacetazone reactions.
Munthali MM; Warndoff DK; Koka CW; Glynn JR; Salaniponi FL
Trans R Soc Trop Med Hyg; 1995; 89(2):238. PubMed ID: 7539955
[No Abstract] [Full Text] [Related]
22. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
[TBL] [Abstract][Full Text] [Related]
23. [Cutaneous reactions to thiacetazone (TB1) (author's transl)].
Strobel M; Ndiaye B; Marchand JP; Jovet JC
Rev Fr Mal Respir; 1979; 7(5):467-70. PubMed ID: 95055
[TBL] [Abstract][Full Text] [Related]
24. Severe hypersensitivity reactions among HIV-seropositive patients with tuberculosis treated with thioacetazone.
Wkly Epidemiol Rec; 1992 Jan; 67(1-2):1-3. PubMed ID: 1371055
[No Abstract] [Full Text] [Related]
25. Diagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons.
Lehloenya RJ; Todd G; Wallace J; Ngwanya MR; Muloiwa R; Dheda K
Br J Dermatol; 2016 Jul; 175(1):150-6. PubMed ID: 26918554
[TBL] [Abstract][Full Text] [Related]
26. Reactions to thiacetazone.
Sarma OA
Indian J Chest Dis Allied Sci; 1976 Jan; 18(1):51-5. PubMed ID: 57922
[No Abstract] [Full Text] [Related]
27. Thiacetazone hypersensitivity in two brothers.
Varshney DP; Singhal KC; Siddiqi MA
Indian J Chest Dis Allied Sci; 1977 Jul; 19(3):131-3. PubMed ID: 77253
[No Abstract] [Full Text] [Related]
28. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koula-Shiro S
Cent Afr J Med; 1998 Feb; 44(2):34-7. PubMed ID: 9675969
[TBL] [Abstract][Full Text] [Related]
29. Thiacetazone induced skin reactions after an unusual period.
Mullick RN; Mullick SB
J Indian Med Assoc; 1986 Jun; 84(6):195-6. PubMed ID: 2435812
[No Abstract] [Full Text] [Related]
30. Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients.
Lehloenya RJ; Wallace J; Todd G; Dheda K
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1260-4. PubMed ID: 22747953
[TBL] [Abstract][Full Text] [Related]
31. Thiacetazone skin reaction in Papua New Guinea.
Naraqi S; Temu P
Med J Aust; 1980 May; 1(10):480-1. PubMed ID: 6157976
[TBL] [Abstract][Full Text] [Related]
32. Thiacetazone: time to call a halt? Considerations on the use of thiacetazone in African populations with a high prevalence of human immunodeficiency virus infection.
Elliott AM; Foster SD
Tuber Lung Dis; 1996 Feb; 77(1):27-9. PubMed ID: 8733410
[No Abstract] [Full Text] [Related]
33. Severe cutaneous eruptions caused by thiacetazone used to treat tuberculosis in Rio Grande do Sul, Brazil. Public Health Dermatology Team, Tuberculosis Team, and Epidemiologic Control Unit, Rio Grande do Sul State Department of Health.
Bull Pan Am Health Organ; 1981; 15(2):113-20. PubMed ID: 6173089
[No Abstract] [Full Text] [Related]
34. Cutaneous sensitivity to thiacetazone.
Fegan D; Glennon J
Lancet; 1991 Apr; 337(8748):1036. PubMed ID: 1708068
[No Abstract] [Full Text] [Related]
35. Thiacetazone--avoid like poison or use with care?
Nunn P; Porter J; Winstanley P
Trans R Soc Trop Med Hyg; 1993; 87(5):578-82. PubMed ID: 7505496
[TBL] [Abstract][Full Text] [Related]
36. Severe skin reactions to thiacetazone in east Nepal.
Fegan D; Glennon J
Tubercle; 1991 Dec; 72(4):305-6. PubMed ID: 1725836
[No Abstract] [Full Text] [Related]
37. Stevens-Johnson syndrome due to thiacetazone.
Hussain SA; Saksena HC; Kothari RP
J Indian Med Assoc; 1973 Jan; 60(2):57-9. PubMed ID: 4123241
[No Abstract] [Full Text] [Related]
38. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.
Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP
Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601
[TBL] [Abstract][Full Text] [Related]
39. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre.
Hongthiamthong P; Riantawan P; Subhannachart P; Fuangtong P
J Med Assoc Thai; 1994 Oct; 77(10):520-5. PubMed ID: 7745373
[TBL] [Abstract][Full Text] [Related]
40. [Skin toxicity of thiacetazone (TB1) at a hospital service in Dakar].
Dieng MT; Ndiaye B; Camara C
Dakar Med; 2001; 46(1):1-3. PubMed ID: 15773145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
